Company
United StatesPublic company, NASDAQ: RAREUltragenyx Pharmaceutical Inc. (NASDAQ: RARE), Novato, CA – FDA Inspections
Inspection records and compliance data for Ultragenyx Pharmaceutical Inc. in Novato, CA. 3 FDA inspections on record, 1 Form 483, last inspected July 17, 2025. Publicly traded as NASDAQ: RARE.
Company Profile
This profile covers Ultragenyx Pharmaceutical Inc. based in Novato, CA, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Form 483s
- 1
- Warning letters
- 0
First inspected June 20, 2017. Last inspected July 17, 2025.
Most cited issue areas
- Ensuring compliance with plan and protocol1 inspection
- General responsibilities of sponsors1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 17, 2025 | NAI | Human Drugs · Drug Quality Assurance | 1277227 |
| February 27, 2023 | NAI | Human Drugs · Bioresearch Monitoring | 1199790 |
| June 20, 2017 | VAI | Human Drugs · Bioresearch Monitoring | 1015263 |
FDA documents
Form 483s (1)
Other FDA documents (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Ultragenyx Pharmaceutical Inc.
Stock ticker
RARE
Exchange
NASDAQ
Share price
$16.27
Market cap
$1.7B
Price as of
November 13, 2026
FEI Number
3012208691
Address
60 Leveroni Ct, Novato, CA 94949, United States
Country
United States
ID: 52e0a912-e566-4a1d-89b4-822a2feaf1d0